Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus pneumoniae is a Gram-positive, lancet-shaped, facultative anaerobic bacterium and the primary cause of pneumococcal disease. It colonizes the human nasopharynx and can cause a range of infections, including pneumonia, meningitis, bacteremia, otitis media, and sinusitis. Virulence is primarily attributed to the polysaccharide capsule. Transmission occurs via respiratory droplets.
Antibiotic mechanisms vary (e.g., inhibition of cell wall synthesis, protein synthesis, DNA replication); Vaccines stimulate an immune response to prevent infection.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae (pneumococcus).